Hybio Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.177x

Hybio Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Hybio Pharmaceutical (300199) has a cash flow conversion efficiency ratio of 0.177x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥117.78 Million ≈ $17.23 Million USD) by net assets (CN¥666.08 Million ≈ $97.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hybio Pharmaceutical (2007–2024)

Cash flow conversion efficiency of Hybio Pharmaceutical from 2007 to 2024. This chart illustrates how Hybio Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Hybio Pharmaceutical stock price today for real-time trading data and today's change.

Hybio Pharmaceutical Cash Flow Conversion Ratio Explained

Hybio Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hybio Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hybio Pharmaceutical ranked by their cash flow conversion efficiency. Also see Hybio Pharmaceutical stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Neptune Insurance Holdings Inc. NYSE:NP	-0.124x
Artisan Partners Asset Management Inc NYSE:APAM	0.210x
JOYY Inc NASDAQ:JOYY	0.005x
Sprott Inc. TO:SII	0.144x
Piramal Enterprises Limited NSE:PEL	-0.299x
Ardagh Metal Packaging SA NYSE:AMBP	-0.542x
Yongxing Special Stainless Steel Co Ltd SHE:002756	0.017x
FB Financial Corp NYSE:FBK	0.039x

Annual Cash Flow Conversion Efficiency for Hybio Pharmaceutical (2007–2024)

The table below shows the annual cash flow conversion efficiency of Hybio Pharmaceutical from 2007 to 2024. Review Hybio Pharmaceutical free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥597.05 Million ≈ $87.37 Million	CN¥164.71 Million ≈ $24.10 Million	0.276x	+6209.36%
2023-12-31	CN¥783.21 Million ≈ $114.61 Million	CN¥-3.54 Million ≈ $-517.51K	-0.005x	-137.05%
2022-12-31	CN¥1.30 Billion ≈ $189.78 Million	CN¥15.81 Million ≈ $2.31 Million	0.012x	-87.19%
2021-12-31	CN¥1.65 Billion ≈ $241.15 Million	CN¥156.83 Million ≈ $22.95 Million	0.095x	+232.72%
2020-12-31	CN¥1.68 Billion ≈ $245.53 Million	CN¥47.99 Million ≈ $7.02 Million	0.029x	-38.96%
2019-12-31	CN¥2.23 Billion ≈ $326.77 Million	CN¥104.64 Million ≈ $15.31 Million	0.047x	+238.15%
2018-12-31	CN¥3.39 Billion ≈ $496.31 Million	CN¥47.00 Million ≈ $6.88 Million	0.014x	-74.81%
2017-12-31	CN¥3.88 Billion ≈ $568.47 Million	CN¥213.74 Million ≈ $31.28 Million	0.055x	-33.09%
2016-12-31	CN¥3.60 Billion ≈ $527.46 Million	CN¥296.41 Million ≈ $43.37 Million	0.082x	+56.20%
2015-12-31	CN¥2.64 Billion ≈ $385.92 Million	CN¥138.84 Million ≈ $20.32 Million	0.053x	-55.53%
2014-12-31	CN¥1.30 Billion ≈ $189.67 Million	CN¥153.43 Million ≈ $22.45 Million	0.118x	-13.29%
2013-12-31	CN¥1.12 Billion ≈ $164.51 Million	CN¥153.48 Million ≈ $22.46 Million	0.137x	+59.09%
2012-12-31	CN¥1.02 Billion ≈ $148.68 Million	CN¥87.19 Million ≈ $12.76 Million	0.086x	+15.57%
2011-12-31	CN¥976.09 Million ≈ $142.83 Million	CN¥72.48 Million ≈ $10.61 Million	0.074x	-75.48%
2010-12-31	CN¥180.59 Million ≈ $26.43 Million	CN¥54.69 Million ≈ $8.00 Million	0.303x	+48.18%
2009-12-31	CN¥127.74 Million ≈ $18.69 Million	CN¥26.11 Million ≈ $3.82 Million	0.204x	-55.67%
2008-12-31	CN¥99.23 Million ≈ $14.52 Million	CN¥45.75 Million ≈ $6.69 Million	0.461x	-54.21%
2007-12-31	CN¥48.70 Million ≈ $7.13 Million	CN¥49.04 Million ≈ $7.18 Million	1.007x	--

About Hybio Pharmaceutical

SHE:300199 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.74 Billion

CN¥18.73 Billion CNY

Market Cap Rank

#4992 Global

#785 in China

Share Price

CN¥21.21

Change (1 day)

-3.98%

52-Week Range

CN¥16.36 - CN¥26.71

All Time High

CN¥29.95